Skip to main content
    X

    XBiotech Inc (XBIT)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $2.16
    +0.00 (+0.00%)

    Market Cap: $65.85M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    43%(9/21)
    Avg Surprise
    +345.17%
    PeriodReportedEst.SurpriseB/MYoY
    Jun 26
    Reported Aug 13
    		$-0.22N/AN/ABeat-266.7%
    Mar 26
    Reported May 14
    		$-0.18N/AN/ABeat+49.4%
    Dec 25
    Reported Mar 13
    		$-0.88$0.00N/AMiss-155.9%
    Sep 25
    Reported Nov 12
    		$-0.20$0.00N/AMiss-21.5%
    Jun 25
    Reported Aug 13
    		$-0.06$0.00N/AMiss+85.9%
    Mar 25
    Reported May 14
    		$-0.36N/AN/ABeat-8.7%
    Dec 24
    Reported Mar 18
    		$-0.34N/AN/ABeat-126.3%
    Sep 24
    Reported Nov 13
    		$-0.16N/AN/ABeat+32.0%
    Jun 24
    Reported Aug 12
    		$-0.43N/AN/ABeat-48.7%
    Mar 24
    Reported May 10
    		$-0.33N/AN/ABeat-152.7%
    Dec 23
    Reported Mar 15
    		$-0.15N/AN/ABeat-44.8%
    Sep 23
    Reported Nov 9
    		$-0.24N/AN/ABeat+42.4%
    Jun 23
    Reported Aug 11
    		$-0.29N/AN/ABeat+24.4%
    Mar 23
    Reported May 10
    		$-0.13N/AN/ABeat+27.8%
    Dec 22
    Reported Mar 15
    		$-0.11N/AN/ABeat-75.3%
    Sep 22
    Reported Nov 9
    		$-0.42N/AN/ABeat-281.8%
    Jun 22
    Reported Aug 10
    		$-0.38N/AN/ABeat-533.3%
    Mar 22
    Reported May 10
    		$-0.18N/AN/ABeat-200.0%
    Dec 21
    Reported Mar 15
    		$-0.06$0.02-400.00%Miss+0.0%
    Sep 21
    Reported Nov 9
    		$-0.11$0.03-466.67%Miss-22.2%
    Jun 21
    Reported Aug 9
    		$-0.06$0.03-300.00%Miss+31.0%
    Mar 21
    Reported May 10
    		$-0.06$0.04-250.00%Miss-200.0%
    Dec 20
    Reported Mar 16
    		$-0.06$0.04-250.00%Miss-100.4%
    Sep 20
    Reported Nov 9
    		$-0.09$0.04-325.00%Miss+40.0%
    Jun 20
    Reported Aug 10
    		$-0.09$0.04-317.50%Miss+45.6%
    Mar 20
    Reported May 11
    		$0.06$0.06+0.00%Beat+137.5%
    Dec 19
    Reported Mar 16
    		$14.59$-0.15+9826.67%Beat+8682.4%
    Sep 19
    Reported Nov 12
    		$-0.15$-0.15+0.00%Beat+53.1%
    Jun 19
    Reported Aug 9
    		$-0.16$-0.15-6.67%Miss+50.0%
    Mar 19
    Reported May 9
    		$-0.16$-0.16+0.00%Beat+50.0%
    Dec 18
    Reported Mar 13
    		$-0.17$-0.17+0.00%Beat+22.7%
    Sep 18
    Reported Oct 31
    		$-0.32$-0.14-128.57%Miss-77.8%
    Jun 18
    Reported Aug 9
    		$-0.32$-0.16-100.00%Miss+0.0%
    Mar 18
    Reported May 8
    		$-0.32$-0.11-190.91%Miss+0.0%
    Dec 17
    Reported Mar 16
    		$-0.22N/A+53.19%Beat+56.9%
    Sep 17
    Reported Nov 9
    		$-0.18N/A+61.70%Beat-
    Jun 17
    Reported Aug 8
    		$-0.32$-0.47+31.91%Beat-
    Mar 17
    Reported May 10
    		$-0.32$-0.47+31.91%Beat-
    Dec 16
    Reported Mar 16
    		$-0.51$-0.42-21.43%Miss-

    Dividends

    Dividend Metrics

    Forward Yield0.00%
    Forward Annual Dividend$0.00
    No dividend payments in the selected period.

    Key Metrics

    Valuation
    P/E Ratio-1.46EV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-29.90%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio33.15xQuick Ratio33.15x
    Trading Statistics
    Beta0.80Avg Volume42.42K
    52-Week High$3.4452-Week Low$2.09

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$2.20
    SMA 20$2.19
    SMA 50$2.23
    SMA 200$2.35
    EMA 10$2.19
    EMA 20$2.20
    EMA 50$2.22
    EMA 200$2.36

    MACD

    Line: -0.01Signal: -0.01Hist: 0.00

    ADX

    ADX: 16.5+DI: 22.4-DI: 17.4

    Aroon & PSAR

    Aroon Up88.0
    Aroon Down100.0
    PSAR$2.32

    Bollinger Bands

    Upper Band$2.26
    Lower Band$2.11
    %B Position691%(Upper)
    Band Width0.31

    RSI (14-Day)

    Neutral
    43.9

    Momentum Oscillators

    Stoch %K15.0
    Stoch %D38.9
    Williams %R-85.0
    ROC (10d)-1.8%
    Momentum-0.04
    CCI (20d)-32.7
    MFI (14d)58.8

    Volatility Measures

    ATR (14d)$0.06(2.9%)
    StdDev (20d)0.04
    Hist Vol27.5%(Moderate)

    Volume Flow

    VWAP$2.18
    OBV-1.2M
    AD Line-3.0M
    CMF (20d)-0.281

    Volume Metrics

    Avg Vol (20d)42.6K
    Vol Ratio2.0x(High)
    VWMA (20d)$2.19

    Pivot Points

    R3$2.30
    R2$2.27
    R1$2.21
    Pivot Point$2.18
    S1$2.13
    S2$2.10
    S3$2.04

    Advanced Oscillators

    TSI-4.07
    Ultimate Osc39.1
    KST-11.60

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$0$0$0$0$0$0$0$0$0$0$2.62M$0
    Cost of Revenue$0$0$378,000$0$0$0N/A$0$0$0$434,000$0
    Gross Profit$0$0$-378,000$0$0$0N/A$0$0$0$2.19M$0
    Operating Expenses$6.15M$6.27M$29.75M$6.05M$6.34M$13.55M$8.75M$7.90M$14.97M$10.85M$8.59M$8.52M
    R&D$5.30M$5.21M$25.36M$5.08M$5.34M$11.62M$7.82M$7.13M$12.98M$9.82M$7.80M$7.55M
    SG&A$850,000$1.07M$4.40M$967,000$1.00M$1.93M$927,000$777,000$1.98M$1.03M$782,000$973,000
    Operating Income$-6,146,000$-6,274,000$-29,752,000$-6,047,000$-6,336,000$-13,550,000$-8,748,000$-7,904,000$-14,966,000$-10,853,000$-8,587,000$-8,520,000
    Interest Income$885,000$914,000$1.22M$1.43M$1.53M$1.42M$1.89M$2.17M$2.49M$2.46M$2.60M$2.53M
    Interest Expense$536,000$0$0$0$0$0$1.80M$0$0$0$0$0
    Income Before Tax$-6,682,000$-5,456,000$-26,816,000$-5,906,000$-1,728,000$-10,855,000$-10,549,000$-5,006,000$-13,031,000$-9,977,000$-4,733,000$-7,056,000
    Income Tax Expense$46,000$49,000$76,000$102,000$28,000$29,000$-41,000$9,000$-25,000$25,000$-172,000$308,000
    Net Income$-6,728,000$-5,505,000$-26,892,000$-6,008,000$-1,756,000$-10,884,000$-10,508,000$-5,015,000$-13,006,000$-10,002,000$-4,635,000$-7,364,000
    EBITDA$-7,265,000$-6,038,000$-27,656,000$-6,906,000$-2,819,000$-11,829,000$-12,002,000$-6,733,000$-15,085,000$-12,003,000$-6,903,000$-9,153,000
    EBIT$-7,567,000$-6,370,000$-28,034,000$-7,333,000$-3,258,000$-12,271,000$-12,441,000$-7,172,000$-15,520,000$-12,435,000$-7,337,000$-9,585,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about XBIT

    News

    XBIT Forecast — Price Target — Prediction for 2027

    This article provides a forecast and price target for XBiotech Inc. (XBIT) stock, detailing its current price, historical performance, market capitalization...

    TradingView•10/8/26•Somewhat-Bearish

    XBiotech Inc. SEC Filing (Oct 2, 2026)

    This article announces an SEC filing by XBiotech Inc. (XBIT) on October 2, 2026, categorized as an ARS type. It provides details about the filing's acceptance by the SEC EDGAR system and highlights other recent news...

    Stock Titan•10/3/26•Neutral

    $17.3M in severance is part of a former CEO's 2025 compensation at XBiotech (XBIT).

    XBiotech Inc.'s former CEO, John Simard, received a total compensation of $30.1 million in 2025, which included over $17.3 million in severance pay, $8.5 million in bonuses...

    Stock Titan•10/2/26•Neutral

    XBiotech (NASDAQ:XBIT) Shares Cross Below 200-Day Moving Average - Time to Sell?

    XBiotech (NASDAQ:XBIT) shares recently fell below their 200-day moving average, trading at $2.19, significantly lower than the average of $2.36. The company has a market capitalization of $66.77 million...

    MarketBeat•9/3/26•Bearish

    XBiotech (NASDAQ:XBIT) Issues Quarterly Earnings Results, Misses Estimates By $0.25 EPS

    XBiotech (NASDAQ:XBIT) reported a quarterly loss of $0.22 per share, significantly missing analysts' consensus estimate of a $0.03 profit by $0.25. Following the announcement, XBIT shares fell by $0.13 to $2.33...

    MarketBeat•8/14/26•Bearish

    XBIT Valuation and Fair Value

    P/E
    -1.5x
    PEG
    0.0x
    P/B
    0.5x
    See GNG's fair value

    XBIT Profitability: Margins, ROIC and FCF

    Operating margin
    0.0%
    Net margin
    0.0%
    ROE
    -29.9%

    XBIT Competitors

    CompanyTicker
    Neumora Therapeutics, Inc.NMRA
    Verrica Pharmaceuticals IncVRCA
    Champions Oncology IncCSBR
    Rein Therapeutics IncRNTX
    Spero Therapeutics IncSPRO
    OS Therapies IncorporatedOSTX
    Microbot Medical IncMBOT
    ImmunoPrecise Antibodies Ltd.HYFT

    Sector: Healthcare

    XBIT Bull Case vs Bear Case

    Bear case

    • XBIT beat EPS estimates in 0.0% of its last 8 reported quarters.
    • XBIT's quarterly revenue changed -93.3% year over year.

    XBIT Earnings: Beat Rate and Next Report

    Beat rate
    0 of 8 quarters (0.0%)
    Average surprise
    -333.3%

    XBIT Dividend

    Forward yield
    0.0%

    Frequently Asked Questions About XBIT

    Does XBIT pay dividends?

    XBiotech Inc (XBIT) has a dividend payment track record. See the XBIT dividend history page for its current payment status, TTM yield, and recorded payments.

    What is XBIT's market cap?

    XBiotech Inc (XBIT) has a market capitalization of $65.85M with a current stock price of $2.16.

    Related stocks

    Sector: Healthcare

    All stocks starting with X

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In